Silenseed is a biopharmaceutical company developing RNA interference (RNAi)-based cancer drugs. It offers drugs used together with the delivery system, the LODER (LOcal Drug EluteR), for the treatment of malignant solid tumors. The company focuses on the pancreatic cancer, prostate cancer, and certain brain cancers.